Global Coronary Stents Market is expected to reach USD 6.1 billion by 2022, from USD 5.1 billion in 2015 growing at a CAGR of 2.5% during the forecast period of 2016 to 2022.
Global Coronary Stents Market is segmented based on product types, material, application, absorption rate, drug, end-user, distribution channel, and geography.
For Sample Report: http://databridgemarketresearch.com/reports/global-coronary-stents-market/
On the basis of type, the global coronary stents market is segmented into dual therapy stent, bioresorbable vascular scaffold (BVS), drug eluting stent (DES), bio-engineered stent, bare metal stent. The drug eluting stent market is segmented into biodegradable and non-biodegradable.
Based on material, the market is segmented into stainless steel, cobalt alloy metal, gold, tantalum, nitinol, and polymers. Polymer market is further segmented into silicone, bioerodible polymer, polyethylene and polyurethane.
Based on application, the market is segmented into coronary artery disease, and peripheral artery disease.
To read more about the scope and findings of this report visit: http://databridgemarketresearch.com/coronary-stents-market-poised-grow-2-5/
On the basis of absorption rate, the market is segmented into slow-absorption stents, and fast-absorption stents.
Based on end-user, the market is segmented into Hospitals, Cardiac Centers, Others.
Based on geography, the market report covers data for regions namely North America, Europe, Asia-Pacific, South America, Middle East and Africa and, Rest of the World. The report of this market shares countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa. The report also covers company share analysis for Global, U.S., Europe, Germany, Asia-Pacific, Middle East & Africa, North America and South America.
Global players operating in this market are players operating in this market are Abbott Vascular, SciTech, Boston Scientific Corporation, Medinol Ltd, iVascular SLU, Stentys SA, Elixir Medical Corporation, Inspire MD, Hexacath, Medtronic, Orbusneich, Andramed GmbH, Cordis Corporation, Endocor GmbH, Eurocor GmbH, Comed B.V., MicroPort Scientific Corporation, Degania Silicone Ltd., Amaranth Medical, Inc., Terumo Corporation, Meril Life Sciences Pvt. Ltd., Elixir Medical Corporation, InSitu Technologies Inc., Alvimedica, Biotronik SE & Co. KG, AMG International GmbH, Arthesys, Translumina GmbH, Lepu Medical, Accura, CeloNova BioSciences, Inc., Minvasys, Svelte Medical, B. Braun Melsungen AG and, Eucatech AG among other companies.
To Browse Full Report and Pricing: http://databridgemarketresearch.com/reports/global-coronary-stents-market/
Table of Content:
1. INTRODUCTION
1.1. OVERVIEW OF THE CORONARY STENTS MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL CORONARY STENTS MARKET
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. EPIDEMIOLOGY DATA FORECASTING MODEL
2.4. GLOBAL CORONARY STENTS MARKET: RESEARCH SNAPSHOT
2.5. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL CORONARY STENTS MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.2. RESTRAINTS
4.3.3. OPPURTUNITIES
4.3.4. THREATS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. CORONARY STENTS MARKET, EPIDEMIOLOGY STUDIES
5.1. OVERVIEW
5.2. TOTAL NUMBER OF PERCUTANEOUS CORONARY INTERVENTION (PCI) PROCEDURES PERFORMED; (2010 – 2025)
5.2.1. NORTH AMERICA, BY COUNTRY
5.2.2. EUROPE, BY COUNTRY
5.2.3. ASIA-PACIFIC, BY COUNTRY
5.2.4. REST OF THE WORLD, BY COUNTRY
5.2.5. SOURCES BIBLIOGRAPHY
5.3. PREVALENT POPULATION OF DIAGNOSED ATHEROSCLEROSIS: (2010 – 2025)
5.3.1. NORTH AMERICA, BY COUNTRY
5.3.2. EUROPE, BY COUNTRY
5.3.3. ASIA-PACIFIC, BY COUNTRY
5.3.4. REST OF THE WORLD, BY COUNTRY
5.3.5. SOURCES BIBLIOGRAPHY
5.4. PERCUTANEOUS CORONARY INTERVENTION (PCI) PROCEDURES PERFORMED: FEMORAL ACCESS VS RADIAL ACCESS; (2010 – 2025)
5.4.1. NORTH AMERICA, BY COUNTRY
5.4.2. EUROPE, BY COUNTRY
5.4.3. ASIA-PACIFIC, BY COUNTRY
5.4.4. REST OF THE WORLD, BY COUNTRY
5.4.5. SOURCES BIBLIOGRAPHY
6. CORONARY STENTS MARKET, BY COMPETITIVE MARKET ASSESMENT
6.1. OVERVIEW
6.2. STENT TYPE: TRADITIONAL STENT VS DRUG ELUTING STENT
6.3. SURGERY TYPE: ANGIOPLASTY VS CABG
6.4. SURGERY TYPE: PTCRA VS TRADITIONAL ANGIOPLASTY
6.5. SURGERY TYPE: TRADITIONAL ANGIOPLASTY VS LASER ANGIOPLASTY
7. CORONARY STENTS MARKET, BY PRODUCT TYPE
7.1. OVERVIEW
7.2. DUAL THERAPY STENT (2014 – 2022)
7.3. BIORESORBABLE VASCULAR SCAFFOLD (2014 – 2022)
7.4. DRUG ELUTING STENT (DES), BY FORMULATION (2014 – 2022)
7.4.1. PACLITAXEL
7.4.2. LIMUS-BASED DRUGS
7.5. DRUG ELUTING STENT (DES), BY ABSORBANCE (2014 – 2022)
7.5.1. SLOW-ABSORPTION DES
7.5.2. FAST-ABSORPTION DES
7.6. BIO-ENGINEERED STENT (2014 – 2022)
7.7. BARE METAL STENT (2014 – 2022)
8. CORONARY STENTS MARKET, BY APPLICATION
8.1. OVERVIEW
8.2. CORONARY ARTERY DISEASE (2014 – 2022)
8.3. PERIPHERAL ARTERY DISEASE (2014 – 2022)
9. CORONARY STENTS MARKET, BY END-USER
9.1. OVERVIEW
9.2. HOSPITALS (2014 – 2022)
9.3. CARDIAC CLINICS (2014 – 2022)
9.4. AMBULATORY CENTERS (2014 – 2022)
9.5. OTHERS (2014 – 2022)
10. CORONARY STENTS MARKET, BY GEOGRAPHY
10.1. COUNTRYWISE CORONARY STENTS MARKET, (2014 – 2022)
(ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY) (MARKET VALUE (USD MILLION))
10.1.1. NORTH AMERICA
10.1.1.1. U.S.
10.1.1.2. CANADA
10.1.1.3. MEXICO
10.1.2. EUROPE
10.1.2.1. GERMANY
10.1.2.2. FRANCE
10.1.2.3. U.K.
10.1.2.4. ITALY
10.1.2.5. SPAIN
10.1.2.6. RUSSIA
10.1.2.7. TURKEY
10.1.2.8. BELGIUM
10.1.2.9. NETHERLANDS
10.1.2.10. SWITZERLAND
10.1.2.11. REST OF EUROPE
10.1.3. ASIA-PACIFIC (APAC)
10.1.3.1. JAPAN
10.1.3.2. CHINA
10.1.3.3. SOUTH KOREA
10.1.3.4. INDIA
10.1.3.5. AUSTRALIA
10.1.3.6. SINGAPORE
10.1.3.7. THAILAND
10.1.3.8. MALAYSIA
10.1.3.9. INDONESIA
10.1.3.10. PHILIPPINES
10.1.3.11. REST OF APAC
10.1.4. SOUTH AMERICA
10.1.4.1. BRAZIL
10.1.4.2. REST OF SOUTH AMERICA
10.1.5. MIDDLE EAST AND AFRICA (MEA)
10.1.5.1. SOUTH AFRICA
10.1.5.2. SAUDI ARABIA
10.1.5.3. UNITED ARAB EMIRATES (U.A.E)
10.1.5.4. REST OF MEA
10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
11. CORONARY STENTS MARKET: COMPETITIVE LANDSCAPE
11.1. GLOBAL CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
11.2. U.S. CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
11.3. EUROPE CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
11.4. ASIA-PACIFIC CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
11.5. SOUTH AMERICA CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS
11.6. MERGERS & ACQUISITIONS
11.7. NEW PRODUCT DEVELOPMENT & APPROVALS
11.8. REGULATORY CHANGES
12. CORONARY STENTS MARKET, COMPANY PROFILES
12.1. ABBOTT VASCULAR
12.1.1. OVERVIEW
12.1.2. SWOT ANALYSIS
12.1.3. PRODUCT PORTFOLIO
12.1.4. REVENUE ANALYSIS
12.1.5. ANALYSTS VIEW
12.2. SCITECH
12.2.1. OVERVIEW
12.2.2. SWOT ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. REVENUE ANALYSIS
12.2.5. ANALYSTS VIEW
12.3. BOSTON SCIENTIFIC CORPORATION
12.3.1. OVERVIEW
12.3.2. SWOT ANALYSIS
12.3.3. PRODUCT PORTFOLIO
12.3.4. REVENUE ANALYSIS
12.3.5. ANALYST VIEW
12.4. MEDINOL LTD
12.4.1. OVERVIEW
12.4.2. SWOT ANALYSIS
12.4.3. PRODUCT PORTFOLIO
12.4.4. REVENUE ANALYSIS
12.4.5. ANALYSTS VIEW
12.5. IVASCULAR SLU
12.5.1. OVERVIEW
12.5.2. SWOT ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. REVENUE ANALYSIS
12.5.5. ANALYSTS VIEW
12.6. STENTYS SA
12.6.1. OVERVIEW
12.6.2. SWOT ANALYSIS
12.6.3. PRODUCT PORTFOLIO
12.6.4. REVENUE ANALYSIS
12.6.5. ANALYSTS VIEW
12.7. ELIXIR MEDICAL CORPORATION
12.7.1. OVERVIEW
12.7.2. SWOT ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. REVENUE ANALYSIS
12.7.5. ANALYSTS VIEW
12.8. INSPIRE MD
12.8.1. OVERVIEW
12.8.2. SWOT ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. REVENUE ANALYSIS
12.8.5. ANALYSTS VIEW
12.9. HEXACATH
12.9.1. OVERVIEW
12.9.2. SWOT ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. REVENUE ANALYSIS
12.9.5 . ANALYSTS VIEW
12.10. MEDTRONIC
12.10.1. OVERVIEW
12.10.2. SWOT ANALYSIS
12.10.3. PRODUCT PORTFOLIO
12.10.4. REVENUE ANALYSIS
12.10.5. ANALYSTS VIEW
12.11. ORBUSNEICH
12.11.1. OVERVIEW
12.11.2. SWOT ANALYSIS
12.11.3. PRODUCT PORTFOLIO
12.11.4. REVENUE ANALYSIS
12.11.5. ANALYSTS VIEW
12.12. ANDRAMED GMBH
12.12.1. OVERVIEW
12.12.2. SWOT ANALYSIS
12.12.3. PRODUCT PORTFOLIO
12.12.4. REVENUE ANALYSIS
12.12.5. ANALYSTS VIEW
12.13. CORDIS CORPORATION
12.13.1. OVERVIEW
12.13.2. SWOT ANALYSIS
12.13.3. PRODUCT PORTFOLIO
12.13.4. REVENUE ANALYSIS
12.13.5. ANALYSTS VIEW
12.14. ENDOCOR GMBH
12.14.1. OVERVIEW
12.14.2. SWOT ANALYSIS
12.14.3. PRODUCT PORTFOLIO
12.14.4. REVENUE ANALYSIS
12.14.5. ANALYSTS VIEW
12.15. EUROCOR GMBH
12.15.1. OVERVIEW
12.15.2. SWOT ANALYSIS
12.15.3. PRODUCT PORTFOLIO
12.15.4. REVENUE ANALYSIS
12.15.5. ANALYSTS VIEW
12.16. COMED B.V.
12.16.1. OVERVIEW
12.16.2. SWOT ANALYSIS
12.16.3. PRODUCT PORTFOLIO
12.16.4. REVENUE ANALYSIS
12.16.5. ANALYSTS VIEW
12.17. MICROPORT SCIENTIFIC CORPORATION
12.17.1. OVERVIEW
12.17.2. SWOT ANALYSIS
12.17.3. PRODUCT PORTFOLIO
12.17.5. ANALYSTS VIEW
12.18. DEGANIA SILICONE LTD.
12.18.1. OVERVIEW
12.18.2. SWOT ANALYSIS
12.18.3. PRODUCT PORTFOLIO
12.18.4. REVENUE ANALYSIS
12.18.5. ANALYSTS VIEW
12.19. TERUMO CORPORATION
12.19.1. OVERVIEW
12.19.2. SWOT ANALYSIS
12.19.3. PRODUCT PORTFOLIO
12.19.4. REVENUE ANALYSIS
12.19.5. ANALYSTS VIEW
12.20. MERIL LIFE SCIENCES PVT. LTD.
12.20.1. OVERVIEW
12.20.2. SWOT ANALYSIS
12.20.3. PRODUCT PORTFOLIO
12.20.4. REVENUE ANALYSIS
12.20.5. ANALYSTS VIEW
12.21. ALVIMEDICA
12.21.1. OVERVIEW
12.21.2. SWOT ANALYSIS
12.21.3. PRODUCT PORTFOLIO
12.21.4. REVENUE ANALYSIS
12.21.5. ANALYSTS VIEW
12.22. ELIXIR MEDICAL CORPORATION
12.22.1. OVERVIEW
12.22.2. SWOT ANALYSIS
12.22.3. PRODUCT PORTFOLIO
12.22.4. REVENUE ANALYSIS
12.22.5. ANALYSTS VIEW
12.23. INSITU TECHNOLOGIES INC.
12.23.1. OVERVIEW
12.23.2. SWOT ANALYSIS
12.23.3. PRODUCT PORTFOLIO
12.23.4. REVENUE ANALYSIS
12.23.5. ANALYSTS VIEW
12.24. BIOTRONIK SE & CO. KG
12.24.1. OVERVIEW
12.24.2. SWOT ANALYSIS
12.24.3. PRODUCT PORTFOLIO
12.24.4. REVENUE ANALYSIS
12.24.5. ANALYSTS VIEW
12.25. AMG INTERNATIONAL GMBH
12.25.1. OVERVIEW
12.25.2. SWOT ANALYSIS
12.25.3. PRODUCT PORTFOLIO
12.25.4. REVENUE ANALYSIS
12.25.5. ANALYSTS VIEW
12.26. ARTHESYS
12.26.1. OVERVIEW
12.26.2. SWOT ANALYSIS
12.26.3. PRODUCT PORTFOLIO
12.26.4. REVENUE ANALYSIS
12.26.5. ANALYSTS VIEW
12.27. TRANSLUMINA GMBH
12.27.1. OVERVIEW
12.27.2. SWOT ANALYSIS
12.27.3. PRODUCT PORTFOLIO
12.27.4. REVENUE ANALYSIS
12.27.5. ANALYSTS VIEW
12.28. LEPU MEDICAL
12.28.1. OVERVIEW
12.28.2. SWOT ANALYSIS
12.28.3. PRODUCT PORTFOLIO
12.28.4. REVENUE ANALYSIS
12.28.5. ANALYSTS VIEW
12.29. ACCURA
12.29.1. OVERVIEW
12.29.2. SWOT ANALYSIS
12.29.3. PRODUCT PORTFOLIO
12.29.4. REVENUE ANALYSIS
12.29.5. ANALYSTS VIEW
12.30. CELONOVA BIOSCIENCES, INC.
12.30.1. OVERVIEW
12.30.2. SWOT ANALYSIS
12.30.3. PRODUCT PORTFOLIO
12.30.4. REVENUE ANALYSIS
12.30.5. ANALYSTS VIEW
12.31. MINVASYS
12.31.1. OVERVIEW
12.31.2. SWOT ANALYSIS
12.31.3. PRODUCT PORTFOLIO
12.31.4. REVENUE ANALYSIS
12.31.5. ANALYSTS VIEW
12.32. SVELTE MEDICAL
12.32.1. OVERVIEW
12.32.2. SWOT ANALYSIS
12.32.3. PRODUCT PORTFOLIO
12.32.4. REVENUE ANALYSIS
12.32.5. ANALYSTS VIEW
12.33. B. BRAUN MELSUNGEN AG
12.33.1. OVERVIEW
12.33.2. SWOT ANALYSIS
12.33.3. PRODUCT PORTFOLIO
12.33.4. REVENUE ANALYSIS
12.33.5. ANALYSTS VIEW
12.34. EUCATECH AG
12.34.1. OVERVIEW
12.34.2. SWOT ANALYSIS
12.34.3. PRODUCT PORTFOLIO
12.34.4. REVENUE ANALYSIS
12.34.5. ANALYSTS VIEW
13. APPENDIX
14. ABOUT DATA BRIDGE MARKET RESEARCH
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Other Reports:
Global Absorbable and Non-Absorbable Sutures Market- Trends and Forecast to 2022
By Product Type (Automated Suturing Devices (Disposable, Reusable), Sutures (Absorbable (Natural, Synthetic (Vicryl, Monocryl, Polydioxanone, Polyglycolic)), Non-Absorbable (Nylon, Prolene, Stainless Steel))), By Surgery Type (Cardiovascular, Ortho
Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Shubham Dwivedi
Email:Send Email
Phone: +1-888-387-2818
Address:Mega Center, Magarpatta City
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-coronary-stents-market/
